Invuity Stock Price, News & Analysis (NASDAQ:IVTY)

$5.30 -0.10 (-1.85 %)
(As of 01/18/2018 11:07 AM ET)
Previous Close$5.40
Today's Range$5.15 - $5.45
52-Week Range$5.15 - $9.70
Volume541,200 shs
Average Volume225,664 shs
Market Capitalization$92.55 million
P/E Ratio-2.15
Dividend YieldN/A
Beta-0.25

About Invuity (NASDAQ:IVTY)

Invuity logoInvuity, Inc., a medical technology company, develops various surgical devices to address various surgical procedures in the United States. The company integrates its intelligent photonics technology platform into its single-use and reusable advanced surgical devices to address various critical intracavity illumination and visualization challenges. It offers various illuminated surgical devices, including Eikon LT Illuminated and Eikon illuminated retractor systems for breast oncology/oncoplastic/general/orthopedics surgeries; Saber Yankauer, a handheld illuminator for orthopedic/spine/cardiothoracic/breast/general surgeries; and Saber Frazier, a handheld illuminator for spine/orthopedic/neurosurgery surgeries. The company also provides Eika illuminated retractor systems for anterior neck approaches comprising thyroid and cervical spine surgeries; Breiten illuminated retractor systems for spine surgeries; Eipex illuminated retractor systems for spine/orthopedic surgeries; Eivector illuminated and Eiberg Illuminated retractor systems for orthopedic surgeries; and Waveguide XT system, a drop-in intracavity illuminator for spine surgeries. Invuity, Inc. sells its devices through its direct sales representatives and independent sales agents; and directly to hospitals and surgeons, as well as to third-party medical device manufacturers. The company was formerly known as Spotlight Surgical, Inc. and changed its name to Invuity, Inc. in 2007. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California.

Receive IVTY News and Ratings via Email

Sign-up to receive the latest news and ratings for IVTY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:IVTY
CUSIPN/A
Phone415-655-2100

Debt

Debt-to-Equity Ratio5.39%
Current Ratio2.90%
Quick Ratio2.47%

Price-To-Earnings

Trailing P/E Ratio-2.14574030064656
Forward P/E Ratio-2.20
P/E GrowthN/A

Sales & Book Value

Annual Sales$32.46 million
Price / Sales2.80
Cash FlowN/A
Price / CashN/A
Book Value$2.03 per share
Price / Book2.61

Profitability

Trailing EPS($2.47)
Net Income$-40,600,000.00
Net Margins-111.43%
Return on Equity-212.38%
Return on Assets-73.58%

Miscellaneous

Employees172
Outstanding Shares17,140,000

Invuity (NASDAQ:IVTY) Frequently Asked Questions

What is Invuity's stock symbol?

Invuity trades on the NASDAQ under the ticker symbol "IVTY."

How were Invuity's earnings last quarter?

Invuity, Inc. (NASDAQ:IVTY) announced its quarterly earnings results on Tuesday, November, 7th. The medical instruments supplier reported ($0.52) EPS for the quarter, beating the consensus estimate of ($0.56) by $0.04. The medical instruments supplier had revenue of $9.60 million for the quarter, compared to the consensus estimate of $9.87 million. Invuity had a negative return on equity of 212.38% and a negative net margin of 111.43%. View Invuity's Earnings History.

When will Invuity make its next earnings announcement?

Invuity is scheduled to release their next quarterly earnings announcement on Monday, February, 12th 2018. View Earnings Estimates for Invuity.

Where is Invuity's stock going? Where will Invuity's stock price be in 2018?

4 brokers have issued 12 month price objectives for Invuity's stock. Their forecasts range from $10.00 to $13.00. On average, they expect Invuity's share price to reach $11.67 in the next twelve months. View Analyst Ratings for Invuity.

What are Wall Street analysts saying about Invuity stock?

Here are some recent quotes from research analysts about Invuity stock:

  • 1. According to Zacks Investment Research, "Invuity, Inc. is a medical technology company. Its products include Eikon Illuminated Retractor System, Saber Yankauer, Saber Frazier, Eika Illuminated Retractor System, Breiten Illuminated Retractor System, Eipex Illuminated Retractor System, Eivector Illuminated Retractor System and Waveguide XT System. The Company sells its devices through its direct sales representatives and original equipment manufacturers of surgical systems. Invuity, Inc. is based in San Francisco, California. " (1/10/2018)
  • 2. Stifel Nicolaus analysts commented, "Following Invuity's early January top-line pre-announcement giving a potential $9.1M-$9.3M revenue range, the company's full 4Q16 release and call provided both more positive details on the quarter and critical revenue measures, all of which suggests the business has stabilized after slower than expected 3Q16 results. At $9.4M, 4Q16 sales were a touch ahead of the company's preliminary range. Encouragingly, revenue per account at $12,100 (+10% Y/Y, 5% Q/Q) -- a critical measure for assessing the company's "go-deep" strategy -- appears stable. Equally impressive, the company continued to expand its active hospital account base which now stands at 745 (+41% Y/Y). Management again reaffirmed 2017 top-line guidance of $42M-$44M, which, in our view, could prove conservative given 4Q16 stable revenue/account, new accounts adds, and "modest" contribution from the mid-year 2017 expected full launch of PhotonBlade. We continue to believe Invuity's highly differentiated, and expanding, portfolio of procedure enhancing technologies will continue to demonstrate meaningful growth potential across a broad array of medical specialties. At current valuation levels, 1.6x 2018 EV/R (peer group: ~3.0x), Invuity would appear undervalued, given the company's significant top-line growth outlook. We rate Invuity shares Buy with a now higher $9 (from $8) target price." (2/15/2017)

Who are some of Invuity's key competitors?

When did Invuity IPO?

(IVTY) raised $48 million in an initial public offering (IPO) on the week of June 15th 2015. The company issued 4,000,000 shares at $12.00 per share. Piper Jaffray, Leerink Partners and Stifel acted as the underwriters for the IPO and William Blair was co-manager.

Who owns Invuity stock?

Invuity's stock is owned by a number of of retail and institutional investors. Top institutional investors include DISCOVERY GROUP I, LLC (5.90%). Company insiders that own Invuity stock include Alex Vayser, Eric W Roberts, Gregory T Lucier, James E Flynn, James H Mackaness, Philip M Sawyer, Reza Zadno and Robert Gerberich. View Institutional Ownership Trends for Invuity.

How do I buy Invuity stock?

Shares of Invuity can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Invuity's stock price today?

One share of Invuity stock can currently be purchased for approximately $5.30.

How big of a company is Invuity?

Invuity has a market capitalization of $92.55 million and generates $32.46 million in revenue each year. The medical instruments supplier earns $-40,600,000.00 in net income (profit) each year or ($2.47) on an earnings per share basis. Invuity employs 172 workers across the globe.

How can I contact Invuity?

Invuity's mailing address is 444 DE HARO STREET, San Francisco CA, 94107. The medical instruments supplier can be reached via phone at 415-655-2100 or via email at [email protected]


MarketBeat Community Rating for Invuity (IVTY)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  114 (Vote Outperform)
Underperform Votes:  99 (Vote Underperform)
Total Votes:  213
MarketBeat's community ratings are surveys of what our community members think about Invuity and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Invuity (NASDAQ:IVTY) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $11.67$11.67$11.00$16.50
Price Target Upside: 38.07% upside38.07% upside41.03% upside137.41% upside

Invuity (NASDAQ:IVTY) Consensus Price Target History

Price Target History for Invuity (NASDAQ:IVTY)

Invuity (NASDAQ:IVTY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/10/2017Piper Jaffray CompaniesReiterated RatingBuy$12.00N/AView Rating Details
9/26/2017Northland SecuritiesReiterated RatingBuy$13.00LowView Rating Details
5/23/2017William BlairReiterated RatingBuyLowView Rating Details
4/27/2017Stifel NicolausReiterated RatingBuy -> Buy$9.00 -> $10.00HighView Rating Details
9/19/2016Lake Street CapitalInitiated CoverageBuy$18.00 -> $18.00N/AView Rating Details
8/29/2016Craig HallumInitiated CoverageBuy$25.00N/AView Rating Details
6/23/2016Leerink SwannReiterated RatingBuy$15.00N/AView Rating Details
(Data available from 1/18/2016 forward)

Earnings

Invuity (NASDAQ:IVTY) Earnings History and Estimates Chart

Earnings by Quarter for Invuity (NASDAQ:IVTY)

Invuity (NASDAQ IVTY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/12/2018($0.50)N/AView Earnings Details
11/7/2017Q3 2017($0.56)($0.52)$9.87 million$9.60 millionViewN/AView Earnings Details
7/25/2017Q2 2017($0.54)($0.61)$10.30 million$9.77 millionViewN/AView Earnings Details
4/26/2017Q1 2017($0.61)($0.64)$8.71 million$9.02 millionViewN/AView Earnings Details
2/14/2017Q4 2016($0.56)($0.56)$9.14 million$9.36 millionViewListenView Earnings Details
11/3/2016Q3($0.62)($0.56)$9.29 million$8.48 millionViewListenView Earnings Details
7/19/2016Q2($0.81)($0.76)$8.04 million$8.20 millionViewListenView Earnings Details
5/5/2016Q1($0.68)($0.90)$6.10 million$6.40 millionViewListenView Earnings Details
2/24/2016Q4($0.72)($0.76)$5.77 million$6.25 millionViewListenView Earnings Details
11/10/2015Q315($0.96)($0.69)$5.05 million$5.60 millionViewListenView Earnings Details
8/11/2015Q215($0.75)($3.20)$4.55 million$4.70 millionViewListenView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Invuity (NASDAQ:IVTY) Earnings Estimates

2018 EPS Consensus Estimate: ($1.59)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183($0.50)($0.18)($0.38)
Q2 20183($0.45)($0.10)($0.33)
Q3 20182($0.43)($0.40)($0.42)
Q4 20182($0.53)($0.40)($0.47)
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Invuity (NASDAQ:IVTY)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Invuity (NASDAQ IVTY) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 10.50%
Institutional Ownership Percentage: 69.00%
Insider Trades by Quarter for Invuity (NASDAQ:IVTY)
Institutional Ownership by Quarter for Invuity (NASDAQ:IVTY)

Invuity (NASDAQ IVTY) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/18/2017Eric W RobertsDirectorBuy6,500$7.07$45,955.00106,029View SEC Filing  
5/15/2017Eric W RobertsDirectorBuy5,000$7.88$39,400.00101,529View SEC Filing  
5/9/2017Eric W RobertsDirectorBuy2,000$8.80$17,600.0096,529View SEC Filing  
5/3/2017Reza ZadnoDirectorSell4,000$9.16$36,640.008,800View SEC Filing  
12/14/2016James E FlynnInsiderSell184,796$6.22$1,149,431.12View SEC Filing  
11/8/2016James H MackanessCFOBuy1,700$5.75$9,775.003,700View SEC Filing  
10/17/2016Eric W RobertsDirectorSell1,000$12.08$12,080.0069,945View SEC Filing  
10/6/2016Philip M SawyerInsiderSell900$13.01$11,709.00900View SEC Filing  
10/6/2016Robert GerberichVPSell1,500$12.72$19,080.001,500View SEC Filing  
10/3/2016Alex VayserInsiderSell3,000$13.18$39,540.00168,407View SEC Filing  
9/22/2016Eric W RobertsDirectorSell2,201$14.00$30,814.0069,945View SEC Filing  
9/15/2016Eric W RobertsDirectorSell5,000$13.47$67,350.0069,945View SEC Filing  
9/2/2016Eric W RobertsDirectorSell26,839$14.00$375,746.0069,945View SEC Filing  
9/1/2016Alex VayserInsiderSell7,000$14.00$98,000.00174,702View SEC Filing  
8/24/2016Alex VayserInsiderSell9,000$12.78$115,020.00188,702View SEC Filing  
8/24/2016Robert GerberichVPSell10,500$12.53$131,565.0010,500View SEC Filing  
8/23/2016Eric W RobertsDirectorSell5,000$12.00$60,000.0069,945View SEC Filing  
7/21/2016Alex VayserInsiderSell12,000$12.00$144,000.00190,702View SEC Filing  
7/21/2016Eric W RobertsDirectorSell42,000$12.00$504,000.0069,945View SEC Filing  
6/10/2016Gregory T LucierDirectorBuy8,442$7.56$63,821.5222,261View SEC Filing  
6/7/2016Gregory T LucierDirectorBuy5,601$7.00$39,207.0013,819View SEC Filing  
6/6/2016Gregory T LucierDirectorBuy26,728$6.90$184,423.2026,728View SEC Filing  
5/18/2016James H MackanessCFOBuy2,000$5.08$10,160.002,000View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Invuity (NASDAQ IVTY) News Headlines

Source:
DateHeadline
 Analysts Anticipate Invuity, Inc. (IVTY) Will Post Quarterly Sales of $11.84 Million Analysts Anticipate Invuity, Inc. (IVTY) Will Post Quarterly Sales of $11.84 Million
www.americanbankingnews.com - January 17 at 7:16 PM
-$0.50 EPS Expected for Invuity, Inc. (IVTY) This Quarter-$0.50 EPS Expected for Invuity, Inc. (IVTY) This Quarter
www.americanbankingnews.com - January 15 at 3:30 AM
How Do Analysts See Invuity Inc (NASDAQ:IVTY) Performing Over The Couple Of Years?How Do Analysts See Invuity Inc (NASDAQ:IVTY) Performing Over The Couple Of Years?
finance.yahoo.com - January 7 at 1:45 PM
Invuity, Inc. (IVTY) Given Average Rating of "Buy" by BrokeragesInvuity, Inc. (IVTY) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - January 5 at 10:18 AM
Zacks: Brokerages Anticipate Invuity, Inc. (IVTY) Will Post Quarterly Sales of $11.84 MillionZacks: Brokerages Anticipate Invuity, Inc. (IVTY) Will Post Quarterly Sales of $11.84 Million
www.americanbankingnews.com - December 31 at 12:52 PM
ETFs with exposure to Invuity, Inc. : December 27, 2017ETFs with exposure to Invuity, Inc. : December 27, 2017
finance.yahoo.com - December 27 at 11:39 AM
Invuity, Inc. :IVTY-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017Invuity, Inc. :IVTY-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017
finance.yahoo.com - December 26 at 12:27 PM
Are Invuity Inc’s (NASDAQ:IVTY) Interest Costs Too High?Are Invuity Inc’s (NASDAQ:IVTY) Interest Costs Too High?
finance.yahoo.com - December 15 at 11:47 AM
Invuity, Inc. (IVTY) Expected to Announce Quarterly Sales of $11.84 MillionInvuity, Inc. (IVTY) Expected to Announce Quarterly Sales of $11.84 Million
www.americanbankingnews.com - December 14 at 4:16 PM
Invuity, Inc. (IVTY) Given Consensus Recommendation of "Buy" by BrokeragesInvuity, Inc. (IVTY) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - December 11 at 11:40 AM
$11.84 Million in Sales Expected for Invuity, Inc. (IVTY) This Quarter$11.84 Million in Sales Expected for Invuity, Inc. (IVTY) This Quarter
www.americanbankingnews.com - November 26 at 12:32 PM
 Brokerages Anticipate Invuity, Inc. (IVTY) to Announce -$0.50 EPS Brokerages Anticipate Invuity, Inc. (IVTY) to Announce -$0.50 EPS
www.americanbankingnews.com - November 24 at 5:14 AM
Invuity, Inc. (IVTY) Names Scott Flora to BoardInvuity, Inc. (IVTY) Names Scott Flora to Board
www.streetinsider.com - November 22 at 1:14 AM
Invuity, Inc. (IVTY) Receives Consensus Rating of "Buy" from BrokeragesInvuity, Inc. (IVTY) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - November 16 at 11:02 AM
Invuity to Present at Upcoming Investor ConferencesInvuity to Present at Upcoming Investor Conferences
finance.yahoo.com - November 15 at 3:27 AM
Invuity, Inc. (IVTY) Earns Buy Rating from Piper Jaffray CompaniesInvuity, Inc. (IVTY) Earns Buy Rating from Piper Jaffray Companies
www.americanbankingnews.com - November 11 at 9:42 AM
Q4 2017 EPS Estimates for Invuity, Inc. Cut by Analyst (IVTY)Q4 2017 EPS Estimates for Invuity, Inc. Cut by Analyst (IVTY)
www.americanbankingnews.com - November 10 at 3:04 PM
Brokers Set Expectations for Invuity, Inc.s FY2017 Earnings (IVTY)Brokers Set Expectations for Invuity, Inc.'s FY2017 Earnings (IVTY)
www.americanbankingnews.com - November 10 at 2:42 PM
Leerink Swann Comments on Invuity, Inc.s Q1 2018 Earnings (IVTY)Leerink Swann Comments on Invuity, Inc.'s Q1 2018 Earnings (IVTY)
www.americanbankingnews.com - November 9 at 11:43 AM
Invuity, Inc. (IVTY) Posts  Earnings Results, Beats Estimates By $0.04 EPSInvuity, Inc. (IVTY) Posts Earnings Results, Beats Estimates By $0.04 EPS
www.americanbankingnews.com - November 8 at 6:26 PM
Invuity Inc to Host Earnings CallInvuity Inc to Host Earnings Call
finance.yahoo.com - November 8 at 10:43 AM
Invuity Reports 2017 Third Quarter Financial ResultsInvuity Reports 2017 Third Quarter Financial Results
finance.yahoo.com - November 8 at 10:43 AM
Invuity reports 3Q lossInvuity reports 3Q loss
finance.yahoo.com - November 8 at 10:43 AM
Edited Transcript of IVTY earnings conference call or presentation 7-Nov-17 10:00pm GMTEdited Transcript of IVTY earnings conference call or presentation 7-Nov-17 10:00pm GMT
finance.yahoo.com - November 8 at 10:43 AM
Invuity, Inc. (IVTY) Expected to Announce Earnings of -$0.55 Per ShareInvuity, Inc. (IVTY) Expected to Announce Earnings of -$0.55 Per Share
www.americanbankingnews.com - November 5 at 3:21 AM
Invuity Announces 2017 Third Quarter Financial Results and Conference Call DateInvuity Announces 2017 Third Quarter Financial Results and Conference Call Date
finance.yahoo.com - October 24 at 5:23 PM
Invuity, Inc. (IVTY) Receives Average Recommendation of "Buy" from BrokeragesInvuity, Inc. (IVTY) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - October 22 at 11:02 AM
Invuity, Inc. (IVTY) Set to Announce Quarterly Earnings on ThursdayInvuity, Inc. (IVTY) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - October 19 at 2:32 AM
Invuity Strengthens Senior Management With Appointment of Chief Human Resources OfficerInvuity Strengthens Senior Management With Appointment of Chief Human Resources Officer
finance.yahoo.com - October 18 at 2:51 AM
Invuity, Inc. (IVTY) Expected to Post Q1 2018 Earnings of ($0.47) Per ShareInvuity, Inc. (IVTY) Expected to Post Q1 2018 Earnings of ($0.47) Per Share
www.americanbankingnews.com - September 28 at 10:40 AM
Invuity, Inc. (IVTY) Earns "Buy" Rating from Northland SecuritiesInvuity, Inc. (IVTY) Earns "Buy" Rating from Northland Securities
www.americanbankingnews.com - September 27 at 5:32 PM
Invuity Draws $10 Million Second Tranche Of Term LoanInvuity Draws $10 Million Second Tranche Of Term Loan
www.thestreet.com - September 27 at 4:55 PM
Invuity, Inc. (IVTY) Receives Average Recommendation of "Hold" from AnalystsInvuity, Inc. (IVTY) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - September 27 at 11:00 AM
Invuity Announces Full Commercial Launch of PhotonBlade™Invuity Announces Full Commercial Launch of PhotonBlade™
finance.yahoo.com - September 25 at 6:36 PM
Ekso Bionics Holdings (EKSO) & Invuity (IVTY) Critical ContrastEkso Bionics Holdings (EKSO) & Invuity (IVTY) Critical Contrast
www.americanbankingnews.com - September 18 at 2:30 PM
Invuity to Present at Cantor Fitzgerald Global Healthcare ConferenceInvuity to Present at Cantor Fitzgerald Global Healthcare Conference
finance.yahoo.com - September 14 at 6:39 AM
Invuity (IVTY) and Ekso Bionics Holdings (EKSO) Head-To-Head AnalysisInvuity (IVTY) and Ekso Bionics Holdings (EKSO) Head-To-Head Analysis
www.americanbankingnews.com - September 11 at 10:40 AM
Invuity (IVTY) and Ekso Bionics Holdings (EKSO) Financial ReviewInvuity (IVTY) and Ekso Bionics Holdings (EKSO) Financial Review
www.americanbankingnews.com - September 5 at 10:22 AM
Invuity, Inc. (IVTY) Receives Average Rating of "Hold" from BrokeragesInvuity, Inc. (IVTY) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - September 2 at 10:40 AM
Invuity, Inc. (IVTY) Appoints Daniel Wolterman to BoardInvuity, Inc. (IVTY) Appoints Daniel Wolterman to Board
www.streetinsider.com - September 1 at 1:09 AM
Daniel Wolterman Joins Invuity’s Board of DirectorsDaniel Wolterman Joins Invuity’s Board of Directors
finance.yahoo.com - August 31 at 6:25 AM
Ekso Bionics Holdings (EKSO) vs. Invuity (IVTY) Head-To-Head ComparisonEkso Bionics Holdings (EKSO) vs. Invuity (IVTY) Head-To-Head Comparison
www.americanbankingnews.com - August 28 at 8:10 PM
Invuity, Inc. (IVTY) Sees Significant Increase in Short InterestInvuity, Inc. (IVTY) Sees Significant Increase in Short Interest
www.americanbankingnews.com - August 28 at 1:20 AM
$10.15 Million in Sales Expected for Invuity, Inc. (IVTY) This Quarter$10.15 Million in Sales Expected for Invuity, Inc. (IVTY) This Quarter
www.americanbankingnews.com - August 23 at 11:06 AM
ETFs with exposure to Invuity, Inc. : August 8, 2017ETFs with exposure to Invuity, Inc. : August 8, 2017
finance.yahoo.com - August 8 at 7:43 PM
Invuity, Inc. (IVTY) Receives Consensus Recommendation of "Buy" from AnalystsInvuity, Inc. (IVTY) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - August 8 at 11:04 AM
Head to Head Comparison: Invuity (NASDAQ:IVTY) and Strata Skin Sciences (SSKN)Head to Head Comparison: Invuity (NASDAQ:IVTY) and Strata Skin Sciences (SSKN)
www.americanbankingnews.com - July 30 at 7:27 AM
William Blair Equities Analysts Reduce Earnings Estimates for Invuity, Inc. (NASDAQ:IVTY)William Blair Equities Analysts Reduce Earnings Estimates for Invuity, Inc. (NASDAQ:IVTY)
www.americanbankingnews.com - July 28 at 12:39 PM
Leerink Swann Weighs in on Invuity, Inc.s Q3 2017 Earnings (NASDAQ:IVTY)Leerink Swann Weighs in on Invuity, Inc.'s Q3 2017 Earnings (NASDAQ:IVTY)
www.americanbankingnews.com - July 28 at 11:27 AM
Financial Comparison: Invuity (NASDAQ:IVTY) vs. Strata Skin Sciences (SSKN)Financial Comparison: Invuity (NASDAQ:IVTY) vs. Strata Skin Sciences (SSKN)
www.americanbankingnews.com - July 28 at 8:10 AM

SEC Filings

Invuity (NASDAQ:IVTY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Invuity (NASDAQ:IVTY) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Invuity (NASDAQ IVTY) Stock Chart for Thursday, January, 18, 2018

Loading chart…

This page was last updated on 1/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.